Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

0
Player Avatar crapsshooter (97.14) Submitted: 5/6/2009 9:32:08 AM : Outperform Start Price: $8.78 ALKS Score: +35.04

The next Dendreon let the roller coaster begin. A once a week injectable med for Diabetes is hugh. As iIdiabetic myself this is something I would be very intrested in

Featured Broker Partners


Advertisement